Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05280041
Other study ID # 2021-02221
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 4, 2022
Est. completion date December 31, 2024

Study information

Verified date October 2023
Source University of Applied Sciences and Arts Northwestern Switzerland
Contact Jeannette Brodbeck, PhD
Phone +41 62 957 27 56
Email jeannette.brodbeck@fhnw.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

When someone has lost his or her partner, feelings of grief are normal and usually diminish over time. However, for some people, strong feelings of grief persist. For coping with grief, it is important to learn to accept the loss, experience the pain of grief, adjust to an environment without the deceased person, and withdraw emotional energy and focus it on other relationships. Loss-oriented tasks, such as grief work, and restoration-oriented tasks, such as attending to life changes, engaging in new activities and finding new roles and identities, are both essential. The program is designed to be completed in 10 weeks and recommends that mourners complete one module or topic a week. To examine the benefits of SOLENA, this study will compare the answers of mourners that completed the intervention with the mourners of the control group, which will wait to complete the intervention. The group that completed the intervention is divided in two sub-groups. One group of mourners will complete the intervention in a fixed order, while the other will complete it in a self-tailored order according to their own needs at each moment. Specifically, the study examines how well the self-help program reduces grief, depression symptoms, and loneliness and examines whether the topics of the study modules are presented in a given order or whether participants can work on the topics according to their current needs makes a difference. Ultimately, it is expected that the self-tailored version leads to more benefits than completing SOLENA's modules in a fixed order.


Description:

BACKGROUND AND RATIONALE The death of a spouse is a frequent and very stressful critical life event in later life. The loss of a partner involves the adaptation of daily routines which can be even more challenging when social, physical, and financial resources decline in later life. Grief and psychological distress after the loss of a spouse are normative reactions. For most people, grief intensity weakens to a manageable degree within several weeks or months. However, some individuals are less able to cope with bereavement and show symptoms of disturbed or prolonged grief or adaptation problems. To support coping with the loss of a significant person, the Task model identifies four tasks of mourning, namely accepting the reality of the loss, experiencing the pain of grief, adjusting to an environment without the deceased person, and withdrawing emotional energy and reinvesting it in another relationship. Moreover, the dual-process model of coping with bereavement posits that a dynamic coping process oscillating between loss-oriented tasks such as grief work and restoration-oriented tasks such as attending to life changes is essential for adjustment. Based in these two models, Brodbeck and colleagues developed LIVIA, a text-based self-help online program to support the loss of the spouse, which has proved its efficacy for mourning older adults from a general population. LIVIA is rooted in cognitive behavioural therapy, including the most relevant treatment elements to support the mourning process: exposure, cognitive reappraisal, integration, and restoration as well as self-care and social reengagement treatment components. LIVIA confirmed that the intervention is also efficacious for milder grief symptoms. Compared to the control group, the intervention resulted in significant reductions in grief (d = 0.81), depression (d = 0.59), psychopathological distress (d = 0.39) (primary outcomes), embitterment (d = 0.37), loneliness (d = 0.37) and an increase in life satisfaction (d = -0.41) (secondary outcomes). These gains were maintained over three months. Improvements were similar among participants with low, medium, or high levels of grief at baseline. Therefore, LIVIA provides a promising basis for the development of a more sophisticated and attractive intervention with a more inclusive target group, e.g., mourners of all ages who lost their spouse within the previous six months, while still seeking help for coping with the loss. Apart from extending the target population of the intervention, SOLENA also aims to examine whether the efficacy of LIVIA can be increased by providing a self-tailored version, in which the users can chose the content that is relevant for them and that best fits their current needs. MAIN HYPOTHESES Primary outcome: Grief 1. Efficacy of SOLENA: It is hypothesized that SOLENA will decrease grief significantly compared to the waiting list control group. 2. Stability of the effects: It is hypothesized that SOLENA leads to stable effects on grief across 10 weeks. 3. Comparison of the two active arms: When assessing the presentation format of SOLENA, it is hypothesized that self-tailored arm will lead to higher decrease of grief than the standardised arm. Secondary outcomes: Depression symptoms and perceived loneliness 4. Efficacy of SOLENA: It is hypothesized that SOLENA will decrease depression symptoms and perceived loneliness significantly compared to the waiting list control or treatment as usual group. 5. Stability of the effects: It is hypothesized that SOLENA leads to stable effects on depression symptoms and loneliness across 10 weeks. 6. Comparison of the two active arms: When assessing the presentation format of SOLENA, it is hypothesized that self-tailored arm will lead to higher depression symptoms and loneliness than the standardised arm (superiority hypothesis). RECRUITMENT AND PROCEDURE Recruitment of participants will be conducted via newspaper articles, social media, internet forums, and personal contacts to healthcare workers and churches. Potential participants will find a description of the study and the intervention on the project website, from where they can register at the study. All potential participants can contact the study management to ask questions or clear eventual doubts about the study. This presentation is compiled in accordance with the general guidelines for clinical trials published by the Swiss Ethics Committees on research involving humans for the creation of an informed consent form (ICF) for information transfer. After receiving adequate and sufficient information about the study, the participants will declare consent by signing the ICF. All participants must confirm to have read this information before being allowed to participate in the study. After sending back the signed informed consent, participants will be invited to fill out the baseline measures on REDCap and take part in a short telephone call for screening the inclusion and exclusion criteria. Participants will be randomised to one of the three study arms (fixed-standardized, self-tailored or waiting list control group) and will receive the participant code to connect their data with study condition, ensuring confidentiality and privacy. For 10 weeks, starting at t0, participants will be asked to use the text-based program, SOLENA, to support their grief process and to complete the working alliance (goal & task), change mechanisms measures, and the self-check mood monitoring. At week 10 (t1, post-intervention), participants of the active arms will be asked to complete the primary and secondary measures. At this moment, the waiting-list control group starts using SOLENA and complete baseline measures. At week 20 (t2, follow-up), participants of the active arms will be asked to complete primary and secondary outcome measures to assess stability of program's effects. Also at this time, participants in the waiting list control group will complete post-intervention measures. At week 30 (t3), participants in the waiting list control group will complete follow-up measures. STATISTICAL ANALYSES PLAN Statistical analyses Analyses will be conducted according to the intention-to-treat paradigm. Linear mixed-models, which will be used in this study, allow a different number of measurement points per participants and are thus less sensitive to missing data. Time will be included (pre vs post intervention measures and post intervention vs follow-up measures), group (self-tailored and standardised vs. waiting list control condition) and interaction terms as predictors of the outcome variables. Cohens d will be calculated as effect size for all observed outcome variables. To analyse the longitudinal interplay of predictor and mediator variables, path analyses will be conducted. Analyses will be conducted in SPSS, R and Mplus. Any deviation from the original statistical plan will be described and justified in the final trial report. There are no statistical stopping rules in this trial. SAMPLE SIZE CALCULATIONS The study is mainly powered for the efficacy and stability hypotheses, i.e., the main and interaction effects of the active conditions compared to the waiting list control on the reduction of grief, depression symptoms, and loneliness. The sample size needed was obtained conducting a power analysis with a probability level of .05 and a power of 0.80 with G*Power based on the results of the evaluation of LIVIA, i.e., large to moderate effects. For the comparison of SOLENA and a waiting list condition, it is expected a large effect size of d > .80 or f > .4. For the comparison of the standardised and the self-tailored arms, it is expected a small to moderate effect between f = .25 and .15 in favour of the self-tailored arm. Figure 4 presents the power analyses for a repeated measures ANOVA with a within-between interaction for three groups. A minimum of 85 participants will be included, with an allocation ratio of 35:35:15 for the two active conditions and the waiting list control group. There is no statistical criterion for terminating the trial as more than 85 participants allow more sophisticated moderator analyses for example regarding the time since the loss. Data collection and analysis Data are assessed using online questionnaires programmed in REDCap. Data integrity is enforced through a variety of mechanisms, i.e., referential data rules, valid values, range checks, and consistency checks. The option to choose a value from a list of valid codes and a description of what each code means is available where applicable. Checks are applied at the time of data entry into a specific field. In addition, data on the use of the self-help sessions are collected within the platform. All data will be saved in an anonymous way only identified by a code which is not related to the participant's identity. Servers are protected by high-end firewall systems. Only the researchers directly involved in the study have access to the data. Handling of missing data and drop-outs Dropout are defined as participants who withdraw actively from the intervention after randomisation or who do not fill out the post-intervention in spite of two reminders. As for missing data, by withdrawing actively from the intervention, an e-mail will be sent with a REDCap link to the respective participants asking them to complete the post and follow-up questionnaires, nonetheless, thereby enabling us to conduct intention-to-treat analyses. In any case, all drop-outs are a part of the intent-to-treat sample as they have been randomised and are included in the analyses. Analyses of the extent of missing data will be conducted to explore the missing data patterns and determine the type of missing data (Missing Completely at Random, Missing at Random, Not Missing at Random). Missing values will be substituted using multiple imputations. Sensitivity analyses will explore the impact of the imputation of missing values.


Recruitment information / eligibility

Status Recruiting
Enrollment 85
Est. completion date December 31, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Experience of spousal bereavement - Seeking help for coping with grief or the psychosocial adaptation to a life without the partner - Having access to an internet connection and adequate equipment - Mastery of the German language - An informed consent by the participant. Exclusion Criteria: - Loss less than one month ago - Acute suicidality - Inability to follow the procedures of the study, e.g., due to comprehension problems, visual impairment, lack of sufficient motor skills or severe psychological or somatic disorders which require immediate treatment which impedes the continuous work on the self-help programme.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
SOLENA - Online self-help program for older adults who lost the partner
SOLENA follows the most relevant CBT elements of interventions for prolonged grief: 1) Exposure, e.g., telling the story of the loss; 2) cognitive reappraisal or restructuring of individual dysfunctional thoughts associated with the loss; 3) integration and restoration including self-care and social reengagement; and 4) behavioural activation. SOLENA's content is provided through a conversational virtual agent, Sol, who guides the user through the Study section the CBT intervention itself. In 10 study modules that address either the acceptance of the loss or the restoration and adaptation to a new life, SOLENA includes 1) readings, i.e., texts based about grief related topics that provide the background and rational for the module; and 2) exercises to encourage mourners to actively reflect on their grief and apply their new knowledge to their daily life and to practise the new routines regularly. SOLENA also provides users with the Notebook, Activities, and My Support sections.

Locations

Country Name City State
Switzerland University of Applied Science Northwestern Switzerland Olten

Sponsors (2)

Lead Sponsor Collaborator
Jeannette Brodbeck University of Bern

Country where clinical trial is conducted

Switzerland, 

References & Publications (11)

Aoun SM, Breen LJ, Howting DA, Rumbold B, McNamara B, Hegney D. Who needs bereavement support? A population based survey of bereavement risk and support need. PLoS One. 2015 Mar 26;10(3):e0121101. doi: 10.1371/journal.pone.0121101. eCollection 2015. — View Citation

Boelen PA, de Keijser J, van den Hout MA, van den Bout J. Treatment of complicated grief: a comparison between cognitive-behavioral therapy and supportive counseling. J Consult Clin Psychol. 2007 Apr;75(2):277-84. doi: 10.1037/0022-006X.75.2.277. — View Citation

Brodbeck J, Berger T, Biesold N, Rockstroh F, Znoj HJ. Evaluation of a guided internet-based self-help intervention for older adults after spousal bereavement or separation/divorce: A randomised controlled trial. J Affect Disord. 2019 Jun 1;252:440-449. doi: 10.1016/j.jad.2019.04.008. Epub 2019 Apr 8. — View Citation

Brodbeck J, Berger T, Znoj HJ. An internet-based self-help intervention for older adults after marital bereavement, separation or divorce: study protocol for a randomized controlled trial. Trials. 2017 Jan 13;18(1):21. doi: 10.1186/s13063-016-1759-5. — View Citation

Eisma MC, Boelen PA, van den Bout J, Stroebe W, Schut HA, Lancee J, Stroebe MS. Internet-Based Exposure and Behavioral Activation for Complicated Grief and Rumination: A Randomized Controlled Trial. Behav Ther. 2015 Nov;46(6):729-48. doi: 10.1016/j.beth.2015.05.007. Epub 2015 May 28. — View Citation

Futterman A, Holland JM, Brown PJ, Thompson LW, Gallagher-Thompson D. Factorial validity of the Texas Revised Inventory of Grief-Present scale among bereaved older adults. Psychol Assess. 2010 Sep;22(3):675-87. doi: 10.1037/a0019914. — View Citation

Gomez Penedo JM, Berger T, Grosse Holtforth M, Krieger T, Schroder J, Hohagen F, Meyer B, Moritz S, Klein JP. The Working Alliance Inventory for guided Internet interventions (WAI-I). J Clin Psychol. 2020 Jun;76(6):973-986. doi: 10.1002/jclp.22823. Epub 2019 Jun 25. — View Citation

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x. — View Citation

Martin A, Rief W, Klaiberg A, Braehler E. Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry. 2006 Jan-Feb;28(1):71-7. doi: 10.1016/j.genhosppsych.2005.07.003. — View Citation

Shear K, Frank E, Houck PR, Reynolds CF 3rd. Treatment of complicated grief: a randomized controlled trial. JAMA. 2005 Jun 1;293(21):2601-8. doi: 10.1001/jama.293.21.2601. — View Citation

Stroebe M, Schut H. The dual process model of coping with bereavement: rationale and description. Death Stud. 1999 Apr-May;23(3):197-224. doi: 10.1080/074811899201046. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Other User satisfaction with the program, measured by Patient Satisfaction Questionnaire (ZUF-8) The ZUF-8 is a self-report measure that explores patients' overall satisfaction with the treatment. It contains eight items that are rated on a 4-point scale from 1 - low satisfaction to 4 - high satisfaction. The scale ranges from 1 to 32, higher values indicate higher satisfaction. The instrument was adapted to explore patients' satisfaction with the particular Internet intervention studied in this trial. At week 10 (post-intervention)
Other Stability of improvement in grief: Texas Revised Inventory of Grief - German Version Grief is assessed with the Texas Revised Inventory of Grief - German Version . The TRIG is a widely used measure to assess the severity of grief. The TRIG German version is a 16-item measure to assess the severity of grief from 1 = completely true to 5 = completely false. The scale ranges from 1 to 80, higher values indicate higher levels of grief. At week 20 (follow-up of the intervention)
Other Stability of improvement in depression symptoms measured by The Patient Health Questionnaire (PHQ-9) German version. Depression symptoms will be measured by the Patient Health Questionnaire (PHQ-9). The PHQ-9 corresponds to the depression assessment module, which scores each of the nine diagnostic criteria for major depression in Diagnostic and Statistical Manual Fourth Edition. For each item, answer format is a scale from '0' (not at all) to '3' (nearly every day). The scale ranges from 0 to 27, higher values indicate higher levels of depression. At week 20 (follow-up of the intervention)
Other Stability of improvement in perceived loneliness measured by the Jong Gierveld Loneliness Scale Perceived loneliness will be measured with the de Jong Gierveld Loneliness Scale. This will use the revised and shortened version of the scale that 6 items that resolve into social and emotional subscales. The items can be answered on a 5-point scale from '1' (yes) to '5' (no). The scale ranges from 1 to 30, higher values indicate lower levels of loneliness. At week 20 (follow-up of the intervention)
Other Possible change mechanisms assessed with a 5-item short version based on the Bern patient questionnaire Session outcomes as possible change mechanisms are assessed with a 5-item short version based on the Bern patient questionnaire, including the rating of the overall helpfulness of the module and the matching of participant's needs and presented content, as well as gains in self-esteem, mastery experiences, and insight. Participants will be asked to complete the session outcomes items (Self-reflection survey) after the completion of each submodule and module. The items are rated on a scale ranging from -3 to 3 (not at all; no; rather not; neither; rather yes; yes; yes, exactly). The items can be answered on a 5-point scale from '1' (yes) to '5' (no). The scale ranges from -15 to 15, higher values indicate more improvement. Through intervention completion, from week 1 to week 10.
Other Working alliance during the intervention, Goals and Task scale The working alliance inventory (WAI), is a measure of the therapeutic alliance, a key variable that accounts for treatment outcomes and clients' satisfaction across interventions. The items of the WAI-I were derived from the WAI-SR. We will use the subscale, Task & Goals (T&G) that measures user's agreement with tasks and goals of program. Items are rated on a 5-point Likert scale ranging from 1 = 'never' to 5 = 'always'. The items can be answered on a 5-point scale from '1' (yes) to '5' (no). The scale ranges from 1 to 40, higher values indicate a better working alliance. Week 3, week 6 and week 9 of the intervention
Primary Grief: Texas Revised Inventory of Grief - German Version Grief is assessed with the Texas Revised Inventory of Grief - German Version. The TRIG is a widely used measure to assess the severity of grief. The TRIG German version is a 16-item measure to assess the severity of grief from 1 = completely true to 5 = completely false. The scale ranges from 1 to 80, higher values indicate higher levels of grief. At week 10 (post-intervention)
Secondary Depression symptoms measured by The Patient Health Questionnaire (PHQ-9) German version. Depression symptoms will be measured by the Patient Health Questionnaire (PHQ-9). The PHQ-9 corresponds to the depression assessment module, which scores each of the nine diagnostic criteria for major depression in Diagnostic and Statistical Manual Fourth Edition. For each item, answer format is a scale from '0' (not at all) to '3' (nearly every day). The scale ranges from 0 to 27, higher values indicate higher levels of depression. At week 10 (post-intervention)
Secondary Perceived loneliness measured by the Jong Gierveld Loneliness Scale Perceived loneliness will be measured with the de Jong Gierveld Loneliness Scale. This will use the revised and shortened version of the scale that 6 items that resolve into social and emotional subscales. The items can be answered on a 5-point scale from '1' (yes) to '5' (no). The scale ranges from 1 to 30, higher values indicate lower levels of loneliness. At week 10 (post-intervention)
See also
  Status Clinical Trial Phase
Completed NCT00194844 - Couples Miscarriage Healing Project:Randomized Trial Phase 1/Phase 2
Not yet recruiting NCT03286647 - Oral Hygiene Self-efficacy in Patients With Grief N/A
Recruiting NCT05587517 - A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients Phase 2
Recruiting NCT06102096 - Culturally Adapted iCBT for Arabic-speaking Refugee and Migrant Youth With Common Mental Health Problems N/A
Completed NCT03330145 - Complicated Grief Among Children After a Death From Cancer or Another Cause: A Longitudinal and Prospective Study (CAPS) N/A
Completed NCT02631291 - Promoting Widowed Elders Lifestyle After Loss N/A
Completed NCT04600076 - MOMSonLINE2 ; A Pilot Study Testing Recruitment and Retention of Women of Color to an Online Support Group for Bereaved Mothers N/A
Recruiting NCT05624879 - Accelerated Resolution Therapy for Early Maladaptive Grief N/A
Recruiting NCT04656977 - Providing Psychological and Emotional Support After Perinatal Loss: A Virtual Reality-Based Intervention N/A
Completed NCT04376385 - An Internet-based Self Applied Treatment Program for Prolonged Grief Disorder (PGD) N/A
Completed NCT05156346 - Pragmatic RCT to Assess the Effectiveness of an Online Self-help Programme for Older Adults After Spousal Bereavement N/A
Completed NCT01433653 - Cognitive Behavioral Therapy for Complicated Grief N/A
Recruiting NCT06047808 - Feasibility Study of the Storytelling Through Music Intervention With Bereaved Parents N/A
Recruiting NCT05142605 - Evaluation of Grief Therapy Approaches for Bereaved Parents N/A
Completed NCT03177772 - Group Therapy For Dementia Caregivers At Risk For Complicated Grief
Completed NCT01384942 - Meaning-based Group Counselling for Bereavement Phase 2
Completed NCT01292512 - Bereavement Management - Description, Assessment and Care N/A
Recruiting NCT04883151 - A Psychological Intervention for Families in Pediatric Palliative Care N/A
Active, not recruiting NCT05930912 - Psychiatric Orders in Psychoanalytic Treatment of ASD
Completed NCT02838290 - Occupational Distress in Doctors: The Effect of an Induction Programme N/A